Literature DB >> 23106481

The problem with peptide presumption and the downfall of target-decoy false discovery rates.

Bret Cooper.   

Abstract

In proteomics, peptide-tandem mass spectrum match scores and target-decoy database derived false discovery rates (FDR) are confidence indicators describing the quality of individual and sets of tandem mass spectrum matches. A user can impose a standard by prescribing a limit to these values, equivalent to drawing a line that separates better from poorer quality matches. As a result of setting narrower parent ion mass tolerances to reflect the better resolution of modern mass spectrometers, target-decoy derived FDRs can diminish. FDRs lowered this way consequently drive down the lower-limit for peptide-spectrum match score acceptance. Hence, data quality confidence appears to improve even while fragmentation evidence for some spectra remains weak. One negative outcome can be the presumed identification of peptides that do not exist. The options researchers have to improve proteomics data confidence are not panaceas, and there may be no satisfying solution as long as peptides are identified from a circumscribed list of proteins scientists wish to find.

Mesh:

Substances:

Year:  2012        PMID: 23106481     DOI: 10.1021/ac303051s

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  4 in total

1.  When target-decoy false discovery rate estimations are inaccurate and how to spot instances.

Authors:  Robert J Chalkley
Journal:  J Proteome Res       Date:  2013-01-18       Impact factor: 4.466

2.  Deep coverage of the Escherichia coli proteome enables the assessment of false discovery rates in simple proteogenomic experiments.

Authors:  Karsten Krug; Alejandro Carpy; Gesa Behrends; Katarina Matic; Nelson C Soares; Boris Macek
Journal:  Mol Cell Proteomics       Date:  2013-08-01       Impact factor: 5.911

3.  New mixture models for decoy-free false discovery rate estimation in mass spectrometry proteomics.

Authors:  Yisu Peng; Shantanu Jain; Yong Fuga Li; Michal Greguš; Alexander R Ivanov; Olga Vitek; Predrag Radivojac
Journal:  Bioinformatics       Date:  2020-12-30       Impact factor: 6.937

4.  The potential clinical impact of the release of two drafts of the human proteome.

Authors:  Iakes Ezkurdia; Enrique Calvo; Angela Del Pozo; Jesús Vázquez; Alfonso Valencia; Michael L Tress
Journal:  Expert Rev Proteomics       Date:  2015-10-23       Impact factor: 3.940

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.